InterStim Therapy System, Verify Evaluation System
Medtronic Neuromodulation · Decision date Aug 14, 2026
What did the FDA decide?
FDA records P080025/S350 as a supplement to PMA P080025, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 14, 2026.
FDA approval order statement
implementation of manufacturing controls for Intellis rechargeable lithium-ion batteries.
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Aug 14, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P080025/S350
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic Neuromodulation
- Product code
- QON
- Decision code
- OK30
- Decision date
- Aug 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implanted electrical device intended for treatment of fecal incontinence.
- Applicant
- Medtronic Neuromodulation
- Product code
- QON
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P080025. Subsequent supplements may change the device or its indications.
FDA decision timeline
P080025 · Original PMA
MEDTRONIC INTERSTIM SACRAL NERVE STIMULATION THERAPY SYSTEM
P080025/S322 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S324 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S325 · Related supplement
InterStim Therapy System; Verify Evaluation System
P080025/S326 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S327 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S328 · Related supplement
InterStim Therapy System; Verify Evaluation System
P080025/S329 · Related supplement
InterStim Therapy System; Verify Evaluation System
P080025/S316 · Related supplement
InterStim Therapy System
P080025/S331 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S330 · Related supplement
InterStim Therapy System, Verify Evaluation System (SNS Bowel Neurostimulator 97800); (SNS Bowel Neurostimulators Impl
P080025/S333 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S321 · Related supplement
nterStim Therapy System, Verify Evaluation System
P080025/S334 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S336 · Related supplement
InterStim Therapy System; Verify Evaluation System
P080025/S337 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S338 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S319 · Related supplement
InterStim TM Therapy System, Verify Evaluation System
P080025/S332 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S339 · Related supplement
SNS Bowel Neurostimulator Models 97800, 97810; SNS Bowel Screening Trialing System Model 3531
P080025/S335 · Related supplement
InterStim Therapy System, Verify Evaluation System (SNS Bowel Programming Systems A510, A511, A520, A521)
P080025/S340 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S341 · Related supplement
InterStim Therapy System, Verify Evaluation System (SNS Bowel Neurostimulator)
P080025/S342 · Related supplement
InterStim Therapy System, Verify Evaluation System (SNS Bowel Implantable Neurostimulators 97800, 97810)
P080025/S344 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S343 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S345 · Related supplement
InterStim Therapy System; Verify Evaluation System (3550-05, 3560031, 3889, 978A1, 978B1)
P080025/S346 · Related supplement
InterStim TM Therapy System; Verify Evaluation System; InterStim SNS Bowel Lead Model 978B1
P080025/S347 · Related supplement
InterStim TM Therapy System; Verify TM Evaluation System (97800)
P080025/S348 · Related supplement
InterStim Therapy System
P080025/S349 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S350 received
Application receipt date recorded by FDA.
P080025/S350 · FDA decision
30-Day Notice
P080025/S352 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S351 · Related supplement
lnterStim Therapy System, Verify Evaluation System
P080025/S353 · Related supplement
InterStim Therapy System, Verify Evaluation System
P080025/S354 · Related supplement
InterStim Therapy System, Verify Evaluation System (SNS Bowel Neurostimulator 97800), (SNS Bowel Neurostimulators Impl
Timeline entries are records held by MedtechLedger for P080025. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P080025
Explore the linked device profile
Other records with product code QON
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Axonics Sacral Neuromodulation SystemP190006/S113 | BOSTON SCIENTIFIC CORPORATION | PMA supplement | Aug 7, 2026 | FDA |
Axonics Sacral Neuromodulation SystemP190006/S110 | BOSTON SCIENTIFIC CORPORATION | PMA supplement | Jul 24, 2026 | FDA |
Axonics SNM SystemP190006/S112 | BOSTON SCIENTIFIC CORPORATION | PMA supplement | Jun 17, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Neuromodulation
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 7000 Central Ave., NE, Ms Rcw225, Minneapolis, MN, 55432
Sources and methodology
- Original FDA record: P080025/S350
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records







